AMMON WADDELL: Open Payments
NPI 1780114348 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,284 in 127 payments from 20 companies in 2025. Trend: 2023 $1,715 · 2024 $2,482 · 2025 $2,284
Food & beverage: $2,284
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 30 | $315 |
| ABBVIE INC. | 18 | $233 |
| Janssen Biotech, Inc. | 12 | $216 |
| UCB, Inc. | 8 | $197 |
| Incyte Corporation | 8 | $158 |
| PFIZER INC. | 7 | $154 |
| GENZYME CORPORATION | 7 | $153 |
| Arcutis Biotherapeutics, Inc. | 3 | $136 |
| Lilly USA, LLC | 6 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $114 |
Products named: DUPIXENT, TREMFYA, Bimzelx, OPZELURA, Zoryve, CIBINQO, TALTZ, SKYRIZI.
Industry payments across SC — which companies pay providers there.
